Left atrial appendage occlusion (LAAO) with the Watchman device is a safe and effective intervention for patients with non-valvular atrial fibrillation (NVAF) and end-stage renal disease (ESRD) on hemodialysis to prevent both embolic and bleeding events, a new observational study shows.